Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longitudinal imaging of tau accumulation in the preclinical stages of Alzheimer's disease
2015-003705-42Phase 2Active
- Sponsor
- VU University Medical Center
- Start
- Oct 2015
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Florbetapir in Alzheimer's disease (AD), sponsored by VU University Medical Center. Primary endpoint: Change in [18F]AV-1451 binding over time. Started Oct 2015; status: active.
02
Drugs
Florbetapir
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2015-003705-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003705-42.